Double Regional Anesthesia in Video Assisted Thoracoscopy

Phase 4

Completed

• Conditions: Video Assisted Thoracoscopy; Anesthesia
• Interventions: Drug: Serratus plane block and paravertebral block; Drug: paravertebral block

• Registration Number: NCT03852862
• Lead Sponsor: University Hospital, Rouen

Brief Summary

Monocentric, randomized, controlled, single-blind study who's aim is to demonstrate the efficacy of the association of paravertebral block and serratus plane block with paravertebral block alone

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-02-22
• Study First Submitted QC: 2019-02-22
• Study First Posted: 2019-02-25
• Study Start: 2019-05-08
• Primary Completion: 2020-11-10
• Study Completion: 2020-11-10
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-11
• Last Update Posted: 2021-10-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 112

Inclusion Criteria

• Patient aged 18 to 75 years;
• Programmed for unilateral videothoracoscopy for anatomical resection (segmentectomy, lobectomy);
• Subject affiliated to a social security scheme;
• Subject having signed an informed consent

Exclusion Criteria

• Chronic treatment with opiates;
• Contraindication to administration of morphine;
• Allergy to local anesthetics or contraindications to the use of ropivacaine;
• Contraindication to the realization of paravertebral blocks and serratus;
• Pregnancy, breastfeeding;
• Severe obesity (BMI > 40 kg/m²);
• Renal impairment (GFR < 30 mL/min) or known severe hepatic impairment;
• Difficulties of comprehension preventing the collection of consent and the realization of the study;

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Serratus plane block with paravertebral block	Serratus plane block and paravertebral block	Association of Serratus plane block and paravertebral block for anesthesia
paravertebral block alone	paravertebral block	Paravertebral block for anesthesia

Primary Outcome Measures

Name	Time	Method
Number of opioids drug administrated	24 hours postoperatively

Secondary Outcome Measures

Name	Time	Method
Length of stay in recovery room	24 hours postoperatively
Total duration of hospitalization	during the 28 days postoperatively

Trial Locations

Locations (1)

Rouen University Hospital; 🇫🇷 Rouen, France